Introduction Development of abomasal ulceration is a large concern, especially within
calves; however, there is a paucity of research into the use of gastro protectants in ruminant …

Background: Ruminant species are at risk of developing abomasal ulceration, but there is a
lack of pharmacokinetic data for anti-ulcer therapies, such as the proton pump inhibitor …

Clinical safety data for the use of gastroprotectants in hospitalized ruminants is lacking. In
human patients, multiple adverse effects are possible from the use of pantoprazole including …

Abomasal (gastric) ulceration is a morbidity in sheep, and currently, there is a paucity of
pharmacokinetic and pharmacodynamic data for gastroprotectant drugs reported for this …

Background: Neonatal calves are at risk of developing abomasal ulceration, but there is a
lack of pharmacokinetic data for potential anti-ulcerative therapies, such as pantoprazole, in …

Abomasal ulcers are recognized in sheep of all ages, but research regarding therapeutic
interventions is limited. Proton Pump Inhibitors (PPIs) such as pantoprazole, are clinically …

Simple Summary Hemorrhagic bowel syndrome (HBS) is a poorly understood, sporadic and
often fatal disease in cattle. Although HBS is considered an important disease in dairy cattle …

Limited knowledge exists regarding the use of lidocaine as a prokinetic in ruminants and
camelids to treat gastrointestinal ileus. In this retrospective study, ruminant and camelid …

Hemorrhagic bowel syndrome is a relatively common disease in dairy and beef cattle that
has a high mortality rate. It is classified as acute, sporadic and necrohemorrhagic enteritis …

Hemorrhagic bowel syndrome (HBS) is a poorly understood, sporadic and often fatal
disease in cattle. Although, HBS is considered an important disease in dairy cattle …